Table 2.: Paired Analysis for Advanced Cancer p Values

(Group Data from ref [3]) Test 1* Test 2**
101 zinc group (10/36) vs nonuser group (317/2127) 0.06 0.06
101 zinc group (10/36) vs 1-24 zinc user group (56/469) 0.02 0.01
1-24 zinc group (56/469) vs nonuser group (317/2127) 0.11 0.11
(no. adv cancer cases/total no. cases) *Fisher exact test; **Chi-square
101 zinc group (10/24) vs nonuser group (317/1540) 0.02 0.02
101 zinc group (10/24) vs 1-24 zinc user group (56/338) 0.005 0.005
1-24 zinc group (56/338) vs nonuser group (317/1540) 0.10 0.11
(no. adv cancer cases/sum of adv cases plus organ-confined cases)

Table 2: Paired Analysis for Advanced Cancer p Values

(Group Data from ref [3]) Test 1* Test 2**
101 zinc group (10/36) vs nonuser group (317/2127) 0.06 0.06
101 zinc group (10/36) vs 1-24 zinc user group (56/469) 0.02 0.01
1-24 zinc group (56/469) vs nonuser group (317/2127) 0.11 0.11
(no. adv cancer cases/total no. cases) *Fisher exact test; **Chi-square
101 zinc group (10/24) vs nonuser group (317/1540) 0.02 0.02
101 zinc group (10/24) vs 1-24 zinc user group (56/338) 0.005 0.005
1-24 zinc group (56/338) vs nonuser group (317/1540) 0.10 0.11
(no. adv cancer cases/sum of adv cases plus organ-confined cases)